首页 > 最新文献

International Journal of Cancer Care and Delivery最新文献

英文 中文
Elucidating the role of malnutrition in acute leukemia patients and how it leads to adverse events during hospitalization 阐明营养不良在急性白血病患者中的作用及其如何导致住院期间的不良事件
Pub Date : 2024-04-22 DOI: 10.53876/001c.116592
Aparna Naik, Saad Javaid, Kelly Frasier, Julia Vinagolu-Baur, Vivian Li
Background: Malnutrition negatively impacts patients with hematologic malignancies and is considered a poor marker and indicator of prognosis. Our study explored the association between malnutrition and patients hospitalized with acute leukemia, including patients with both acute myeloid and acute lymphocytic leukemia. Methods: The National Inpatient Sample (NIS) 2019-2020 was analyzed with the use of the International Classification of Diseases, Tenth Revision (ICD-10) codes to identify the patients admitted with the primary diagnosis of Acute Leukemia (that included patients with both Acute Myeloid and Acute Lymphocytic Leukemia). The cohort was further classified into patients who had concurrent malnutrition and those without malnutrition. The association between several outcomes was studied after adjusting for the confounding variables through multivariate regression analysis. Results: A total of 24855 patients with the primary discharge diagnosis of acute leukemia were included in the study. Among these, 3425(13.7%) were found to have concomitant malnutrition. After adjusting for the confounding variables, patients with malnutrition were found to have significantly increased odds of mortality (OR 2.89, 95% CI: 2.11-3.94, P<0.001). Similarly, the length of stay was increased by 9.1
背景:营养不良对血液恶性肿瘤患者有负面影响,被认为是预后不良的标志和指标。我们的研究探讨了营养不良与急性白血病住院患者(包括急性髓细胞白血病和急性淋巴细胞白血病患者)之间的关系。研究方法使用《国际疾病分类第十版》(ICD-10)代码对2019-2020年全国住院患者样本(NIS)进行分析,以确定主要诊断为急性白血病的住院患者(包括急性髓细胞白血病和急性淋巴细胞白血病患者)。该队列进一步分为并发营养不良和无营养不良的患者。通过多变量回归分析对混杂变量进行调整后,研究了几种结果之间的关联。研究结果研究共纳入了 24855 名主要出院诊断为急性白血病的患者。其中,3425 例(13.7%)患者合并营养不良。在对混杂变量进行调整后,发现营养不良患者的死亡几率明显增加(OR 2.89,95% CI:2.11-3.94,P<0.001)。同样,住院时间也增加了 9.1
{"title":"Elucidating the role of malnutrition in acute leukemia patients and how it leads to adverse events during hospitalization","authors":"Aparna Naik, Saad Javaid, Kelly Frasier, Julia Vinagolu-Baur, Vivian Li","doi":"10.53876/001c.116592","DOIUrl":"https://doi.org/10.53876/001c.116592","url":null,"abstract":"Background: Malnutrition negatively impacts patients with hematologic malignancies and is considered a poor marker and indicator of prognosis. Our study explored the association between malnutrition and patients hospitalized with acute leukemia, including patients with both acute myeloid and acute lymphocytic leukemia. Methods: The National Inpatient Sample (NIS) 2019-2020 was analyzed with the use of the International Classification of Diseases, Tenth Revision (ICD-10) codes to identify the patients admitted with the primary diagnosis of Acute Leukemia (that included patients with both Acute Myeloid and Acute Lymphocytic Leukemia). The cohort was further classified into patients who had concurrent malnutrition and those without malnutrition. The association between several outcomes was studied after adjusting for the confounding variables through multivariate regression analysis. Results: A total of 24855 patients with the primary discharge diagnosis of acute leukemia were included in the study. Among these, 3425(13.7%) were found to have concomitant malnutrition. After adjusting for the confounding variables, patients with malnutrition were found to have significantly increased odds of mortality (OR 2.89, 95% CI: 2.11-3.94, P<0.001). Similarly, the length of stay was increased by 9.1","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"10 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140673608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse Bone Disease as Primary Clinical Manifestation in Hispanic Patients with Adult T-cell Leukemia/Lymphoma 成人 T 细胞白血病/淋巴瘤西班牙裔患者以弥漫性骨病为主要临床表现
Pub Date : 2024-04-22 DOI: 10.53876/001c.116590
Kelly Meza, L. Malpica, J. C. Ramos
{"title":"Diffuse Bone Disease as Primary Clinical Manifestation in Hispanic Patients with Adult T-cell Leukemia/Lymphoma","authors":"Kelly Meza, L. Malpica, J. C. Ramos","doi":"10.53876/001c.116590","DOIUrl":"https://doi.org/10.53876/001c.116590","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"18 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140673594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provide needed Oncology Nursing Education to improve patient outcomes 提供所需的肿瘤护理教育,以改善患者的治疗效果
Pub Date : 2024-04-22 DOI: 10.53876/001c.116597
Judy Delismon
{"title":"Provide needed Oncology Nursing Education to improve patient outcomes","authors":"Judy Delismon","doi":"10.53876/001c.116597","DOIUrl":"https://doi.org/10.53876/001c.116597","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140677226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Report on the Keynote Address and Symposium on Research in Health Disparities in the USA 主旨发言和美国健康差距研究专题讨论会报告
Pub Date : 2024-01-02 DOI: 10.53876/001c.91540
S. Kareff, H. N. Aguila, Candace J. Chow, Anna Marsden, Reuben R. Cano, Ana María López
Ensuring a diverse cancer research workforce remains challenging despite national recommendations and pathway programs dedicated to this mission. A panel composed of researchers, educators, and implementation scientists convened at the Binaytara Foundation’s 2023 Summit on Cancer Health Disparities to discuss funded pathway opportunities, share case examples, and outline best practices to achieve a diverse workforce and support research in cancer health equity. The panelists highlighted existing pathway opportunities through the National Cancer Institute’s Center to Reduce Health Disparities and illustrated specific funded examples, such as the University of Utah’s Huntsman Cancer Institute’s PathMaker program, the University of Utah’s postbaccalaureate program, and NIH diversity supplement mechanisms. Programmatic examples were illustrated with success stories from the panel. The panelists concluded with the following insights for successful pathway implementation: 1) Since a diverse research workforce benefits society, investing in training and funding mechanisms is critical to promote individual and societal success in making progress towards cancer health equity; 2) A holistic, inclusive, and pathway-focused approach can successfully support, retain, and promote students, trainees, and faculty underrepresented in medicine and science; and 3) An inclusive workforce is best prepared to meet the needs of the diverse communities we serve.
尽管国家建议和路径计划都致力于这一使命,但确保癌症研究人员的多元化仍然充满挑战。一个由研究人员、教育工作者和实施科学家组成的小组在比奈塔拉基金会的 2023 年癌症健康差距峰会上讨论了受资助的途径机会、分享了案例并概述了实现多元化人才队伍和支持癌症健康公平研究的最佳实践。小组成员重点介绍了美国国立癌症研究所减少健康差异中心(National Cancer Institute's Center to Reduce Health Disparities)提供的现有途径机会,并举例说明了具体的资助案例,如犹他大学亨茨曼癌症研究所(University of Utah's Huntsman Cancer Institute)的PathMaker计划、犹他大学的学士后计划以及美国国立卫生研究院(NIH)的多元化补充机制。小组成员用成功案例对计划实例进行了说明。小组成员最后就成功实施路径提出了以下见解:1) 由于多元化的研究队伍有益于社会,因此投资于培训和资助机制对于促进个人和社会在实现癌症健康公平方面取得成功至关重要;2) 全面、包容和以途径为重点的方法可以成功地支持、留住和提升在医学和科学领域代表性不足的学生、受训人员和教师;3) 包容性的人才队伍是满足我们所服务的多元化社区需求的最佳准备。
{"title":"A Report on the Keynote Address and Symposium on Research in Health Disparities in the USA","authors":"S. Kareff, H. N. Aguila, Candace J. Chow, Anna Marsden, Reuben R. Cano, Ana María López","doi":"10.53876/001c.91540","DOIUrl":"https://doi.org/10.53876/001c.91540","url":null,"abstract":"Ensuring a diverse cancer research workforce remains challenging despite national recommendations and pathway programs dedicated to this mission. A panel composed of researchers, educators, and implementation scientists convened at the Binaytara Foundation’s 2023 Summit on Cancer Health Disparities to discuss funded pathway opportunities, share case examples, and outline best practices to achieve a diverse workforce and support research in cancer health equity. The panelists highlighted existing pathway opportunities through the National Cancer Institute’s Center to Reduce Health Disparities and illustrated specific funded examples, such as the University of Utah’s Huntsman Cancer Institute’s PathMaker program, the University of Utah’s postbaccalaureate program, and NIH diversity supplement mechanisms. Programmatic examples were illustrated with success stories from the panel. The panelists concluded with the following insights for successful pathway implementation: 1) Since a diverse research workforce benefits society, investing in training and funding mechanisms is critical to promote individual and societal success in making progress towards cancer health equity; 2) A holistic, inclusive, and pathway-focused approach can successfully support, retain, and promote students, trainees, and faculty underrepresented in medicine and science; and 3) An inclusive workforce is best prepared to meet the needs of the diverse communities we serve.","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"15 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139452784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of patients with chronic myeloid leukemia after more than 10 years of follow-up 慢性髓性白血病患者随访 10 多年后的结果
Pub Date : 2023-12-28 DOI: 10.53876/001c.91241
F. Haddad, K. Sasaki, G. Issa, Y. Alvarado, N. Pemmaraju, Jeffrey Skinner, S. Dellasala, T. Kadia, L. Masarová, M. Yilmaz, G. Garcia-Manero, S. Pierce, Elias Jabbour, H. Kantarjian
{"title":"Outcome of patients with chronic myeloid leukemia after more than 10 years of follow-up","authors":"F. Haddad, K. Sasaki, G. Issa, Y. Alvarado, N. Pemmaraju, Jeffrey Skinner, S. Dellasala, T. Kadia, L. Masarová, M. Yilmaz, G. Garcia-Manero, S. Pierce, Elias Jabbour, H. Kantarjian","doi":"10.53876/001c.91241","DOIUrl":"https://doi.org/10.53876/001c.91241","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"76 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139151882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Efficacy and Safety of EGFR-TKIs in African American Patients with EGFR-mutated NSCLC 评估表皮生长因子受体突变 NSCLC 非裔美国患者使用表皮生长因子受体-TKIs 的疗效和安全性
Pub Date : 2023-12-07 DOI: 10.53876/001c.90833
Kevin Chang, D. Uprety, Leo Reap
{"title":"Assessment of Efficacy and Safety of EGFR-TKIs in African American Patients with EGFR-mutated NSCLC","authors":"Kevin Chang, D. Uprety, Leo Reap","doi":"10.53876/001c.90833","DOIUrl":"https://doi.org/10.53876/001c.90833","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"32 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138594192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Area Deprivation Index (ADI) among Patients with Breast Cancer in Buffalo 水牛城乳腺癌患者的地区贫困指数(ADI)
Pub Date : 2023-12-07 DOI: 10.53876/001c.90313
Malak Alharbi, Arya Mariam Roy, Archit Patel, Ankita Kapoor, Kristopher Attwood, Kayla Catalfamo, Angela Omilian, Elizabeth Bouchard, Amy Early, Tracey O’Connor, E. Levine, Shipra Gandhi
{"title":"Area Deprivation Index (ADI) among Patients with Breast Cancer in Buffalo","authors":"Malak Alharbi, Arya Mariam Roy, Archit Patel, Ankita Kapoor, Kristopher Attwood, Kayla Catalfamo, Angela Omilian, Elizabeth Bouchard, Amy Early, Tracey O’Connor, E. Levine, Shipra Gandhi","doi":"10.53876/001c.90313","DOIUrl":"https://doi.org/10.53876/001c.90313","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138592859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma: feasibility, safety and efficacy in a real-world setting Lisocabtagene maraleucel 治疗复发或难治性大 B 细胞淋巴瘤:真实世界环境中的可行性、安全性和有效性
Pub Date : 2023-12-07 DOI: 10.53876/001c.90694
A. Portuguese, Aya Albittar, Emily C Liang, Jennifer J Huang, A. Hirayama, Erik L. Kimble, Lorenzo Iovino, Ajay K Gopal, M. Shadman, Brian Till, H. Kiem, Filippo Milano, A. Chapuis, Folashade Otegbeye, Ryan D Cassaday, D. G. Maloney, J. Gauthier
{"title":"Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma: feasibility, safety and efficacy in a real-world setting","authors":"A. Portuguese, Aya Albittar, Emily C Liang, Jennifer J Huang, A. Hirayama, Erik L. Kimble, Lorenzo Iovino, Ajay K Gopal, M. Shadman, Brian Till, H. Kiem, Filippo Milano, A. Chapuis, Folashade Otegbeye, Ryan D Cassaday, D. G. Maloney, J. Gauthier","doi":"10.53876/001c.90694","DOIUrl":"https://doi.org/10.53876/001c.90694","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138593808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor transcriptomic profiling of patients (pts) with Metastatic Castration Sensitive Prostate Cancer (mCSPC) who do not achieve optimal PSA response to intensified androgen deprivation therapy (ADT-I) 对强化雄激素剥夺疗法(ADT-I)未达到最佳 PSA 反应的转移性钙化敏感性前列腺癌(mCSPC)患者(pts)进行肿瘤转录组学分析
Pub Date : 2023-12-07 DOI: 10.53876/001c.90830
V. Thomas, G. Gebrael, N. Sayegh, N. Tripathi, B. Chigarira, R. Nussenzveig, Kamalakanta Sahu, Haoran Li, J. Brundage, B. Maughan, U. Swami, N. Agarwal
{"title":"Tumor transcriptomic profiling of patients (pts) with Metastatic Castration Sensitive Prostate Cancer (mCSPC) who do not achieve optimal PSA response to intensified androgen deprivation therapy (ADT-I)","authors":"V. Thomas, G. Gebrael, N. Sayegh, N. Tripathi, B. Chigarira, R. Nussenzveig, Kamalakanta Sahu, Haoran Li, J. Brundage, B. Maughan, U. Swami, N. Agarwal","doi":"10.53876/001c.90830","DOIUrl":"https://doi.org/10.53876/001c.90830","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"21 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138592785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnic Variation in Hepatocellular Carcinoma Mutational Profiles Revealed Through Liquid Biopsy: Insights from a Single Institution in California 液体活检揭示的肝细胞癌突变特征的种族差异:来自加利福尼亚州一家机构的启示
Pub Date : 2023-12-07 DOI: 10.53876/001c.90818
Gene T Yoshikawa, Charity Huang, Mir Ali, Salimah Valliani, Hugo Akabane, Zaim Chaudhary, Amir Fathi, Uzair Chaudhary
{"title":"Ethnic Variation in Hepatocellular Carcinoma Mutational Profiles Revealed Through Liquid Biopsy: Insights from a Single Institution in California","authors":"Gene T Yoshikawa, Charity Huang, Mir Ali, Salimah Valliani, Hugo Akabane, Zaim Chaudhary, Amir Fathi, Uzair Chaudhary","doi":"10.53876/001c.90818","DOIUrl":"https://doi.org/10.53876/001c.90818","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"20 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138591474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Cancer Care and Delivery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1